US FDA's 25-point action plan to improve 510(k) process sidesteps controversial reforms
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has issued a plan of 25 actions it intends to implement during 2011 to improve its most commonly used pathway for clearing medical devices: the 510(k), or pre-market notification, programme1-4.